Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue Wipes 2014
 •  Glade Teams with Cirque du Soleil  •  Jumei Picks Up Two Brands  •  Secret's Out To Battle Bullying  •  BabyGanics Makes Crain's NY Fast 50  •  L'OrĂ©al USA To Buy Carol's Daughter
Print

Valeant To Buy Bausch & Lomb



Published May 27, 2013
Related Searches: continue Skin Care international health
Post a comment
Valeant Pharmaceuticals International will pay $8.7 billion to acquire Bausch & Lomb, the eye care company. Under the terms of the deal, Valeant will pay $4.5 billion to the investor group that owns Bausch & Lomb, led by private equity firm Warburg Pincus. It will also spend about $4.2 billion to repay Bausch & Lomb’s debt.

 

The agreement continues the flurry of deal-making in the health care industry, as companies seek to buy the growth they are hard-pressed to generate on their own. Announced merger volume in the sector this year is up 14% from the period a year earlier, even as takeovers have fallen 8%.


This acquisition follows Valeant's April purchase for Obagi skin care for $348 million.

 



blog comments powered by Disqus